Hans Kristian Moen Vollan

Author

Also Known As

H. Vollan, H.K. Moen Vollan, H.K. Vollan, H.K.M. Vollan, Hans Kristian M Vollan, Hans Kristian M. Vollan, Hans Kristian Moen Vollan, Hans Kristian Vollan, Hans Kristian Moen Vollan, Suvi-Katri Leivonen

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Akershus University Hospital Cancer Research UK University of Cambridge

About

Hans Kristian Moen Vollan is an author at Oslo University Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Cell Biology	4	4	318
3	Engineering	3	3	286
4	Health Sciences	3	3	85
5	Biostatistics	2	2	248

Hans Kristian Moen Vollan

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Copynumber: Efficient algorithms for single- and multi-track copy number segmentation Gro Nilsen, Knut Liestøl, Peter Van Loo, BMC Genomics	2012	333
Recurrent PTPRB and PLCG1 mutations in angiosarcoma Sam Behjati, Patrick Tarpey, Helen Sheldon, Nature Genetics MedicineRecurrent PtprbGeneticsReceptor Tyrosine KinaseMolecular Genetics	2014	311
<i>TP53</i> Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance Laxmi Silwal‐Pandit, Hans Kristian Moen Vollan, Suet‐Feung Chin, Clinical Cancer Research	2014	302
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer S Yamamoto, Zhenhua Wu, Hege G. Russnes, Cancer Cell MedicineBreast CancerCancer GeneticsCancer BiologyCell Biology	2014	206
Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients Hege G. Russnes, Hans Kristian Moen Vollan, Ole Christian Lingjærde, Science Translational Medicine	2010	153
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study Siow Ming Lee, Christian Schulz, Kumar Prabhash, The Lancet First-line Atezolizumab MonotherapyMedicinePharmacologyClinical TrialsImmune Checkpoint Inhibitor	2023	142
Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast Cancer Erhan Bilal, Erich Huang, Thea Norman, Science Translational Medicine Breast OncologyEngineeringPrognosisCancer RegistrationBcc Results	2013	129
Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling Erhan Bilal, Janusz Dutkowski, Justin Guinney, PLoS Computational Biology Breast OncologyEngineeringMachine LearningMachine Learning ToolPathology	2013	119
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors Jonas Demeulemeester, David C. Wedge, Hans Kristian Moen Vollan, Nature Communications	2017	109
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells Kristine Kleivi Sahlberg, Vesa Hongisto, Henrik Edgren, Molecular Oncology	2012	92

Page 1